Disparities in the implantation of secondary prevention implantable cardioverter defibrillator in the United States.
SES
disparity
race
sex
ventricular arrythmia
Journal
Pacing and clinical electrophysiology : PACE
ISSN: 1540-8159
Titre abrégé: Pacing Clin Electrophysiol
Pays: United States
ID NLM: 7803944
Informations de publication
Date de publication:
05 Jul 2024
05 Jul 2024
Historique:
received:
14
05
2024
accepted:
18
06
2024
medline:
5
7
2024
pubmed:
5
7
2024
entrez:
5
7
2024
Statut:
aheadofprint
Résumé
The annual incidence of sudden cardiac death is over 300,000 in the United States (US). Historically, inpatient implantation of secondary prevention implantable cardioverter defibrillator (ICD) has been variable and subject to healthcare disparities. To evaluate contemporary practice trends of inpatient secondary prevention ICD implants within the US on the basis of race, sex, and socioeconomic status (SES). The study is a retrospective analysis of the National Inpatient Sample from 2016 to 2020 of adult discharges with a primary diagnosis of ventricular tachycardia (VT), ventricular flutter, and fibrillation (VF). Adjusted ICD implantation rates based on race, sex, and SES and associated temporal trends were calculated using multivariate regression. A total of 193,600 primary VT/VF discharges in the NIS were included in the cohort, of which 57,895 (29.9%) had ICD placement. There was a significant racial and ethnic disparity in ICD placement for Black, Hispanic, Asian, and Native American patients as compared to White patients; adjusted odds ratio (aOR): 0.86 [p < .01], 0.90 [p = .03], 0.81[p < .01], 0.45 [p < .01], respectively. Female patients were also less likely to receive an ICD compared to male patients (aOR: 0.75, p < .01). Disparities in ICD placement remained stable over the study period (p Racial, sex, and SES disparities persisted for secondary prevention ICD implants in the US. An investigation into contributing factors and subsequent approaches are needed to address the modifiable causes of disparities in ICD implantation as these trends have not improved compared to historic data.
Sections du résumé
BACKGROUND
BACKGROUND
The annual incidence of sudden cardiac death is over 300,000 in the United States (US). Historically, inpatient implantation of secondary prevention implantable cardioverter defibrillator (ICD) has been variable and subject to healthcare disparities.
OBJECTIVE
OBJECTIVE
To evaluate contemporary practice trends of inpatient secondary prevention ICD implants within the US on the basis of race, sex, and socioeconomic status (SES).
METHODS
METHODS
The study is a retrospective analysis of the National Inpatient Sample from 2016 to 2020 of adult discharges with a primary diagnosis of ventricular tachycardia (VT), ventricular flutter, and fibrillation (VF). Adjusted ICD implantation rates based on race, sex, and SES and associated temporal trends were calculated using multivariate regression.
RESULTS
RESULTS
A total of 193,600 primary VT/VF discharges in the NIS were included in the cohort, of which 57,895 (29.9%) had ICD placement. There was a significant racial and ethnic disparity in ICD placement for Black, Hispanic, Asian, and Native American patients as compared to White patients; adjusted odds ratio (aOR): 0.86 [p < .01], 0.90 [p = .03], 0.81[p < .01], 0.45 [p < .01], respectively. Female patients were also less likely to receive an ICD compared to male patients (aOR: 0.75, p < .01). Disparities in ICD placement remained stable over the study period (p
CONCLUSION
CONCLUSIONS
Racial, sex, and SES disparities persisted for secondary prevention ICD implants in the US. An investigation into contributing factors and subsequent approaches are needed to address the modifiable causes of disparities in ICD implantation as these trends have not improved compared to historic data.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Al‐Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary. Heart Rhythm. 2018;15:e190‐e252.
Wong CX, Brown A, Lau DH, et al. Epidemiology of sudden cardiac death: global and regional perspectives. Heart, Lung Circ. 2019;28:6‐14.
Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297‐1302.
A comparison of antiarrhythmic‐drug therapy with implantable defibrillators in patients resuscitated from near‐fatal ventricular arrhythmias. N Engl J Med 1997;337:1576‐1584.
Kuck K‐H, Cappato R, Siebels J, Rüppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748‐754.
Munir MB, Alqahtani F, Aljohani S, Bhirud A, Modi S, Alkhouli M. Trends and predictors of implantable cardioverter defibrillator implantation after sudden cardiac arrest: insight from the national inpatient sample. Pacing Clin Electrophysiol. 2018;41:229‐237.
Ho EC, Cheskes S, Angaran P, et al. Implantable cardioverter defibrillator implantation rates after out of hospital cardiac arrest: are the rates guideline‐concordant? Can J Cardiol. 2017;33:1266‐1273.
Boursalie S, MacIntyre C, Sapp JL, et al. Disparities in referral and utilization of implantable cardioverter‐defibrillators for primary prevention of sudden cardiac death. Can J Cardiol. 2023;39:1610‐1616.
Patel NJ, Edla S, Deshmukh A, et al. Gender, racial, and health insurance differences in the trend of Implantable Cardioverter‐Defibrillator (ICD) utilization: a United States experience over the last decade. Clin Cardiol. 2016;39:63‐71.
Groeneveld PW, Heidenreich PA, Garber AM. Racial disparity in cardiac procedures and mortality among long‐term survivors of cardiac arrest. Circulation. 2003;108:286‐291.
HCUP‐US NIS Overview [Internet]. [Cited 2022 Oct 28]. https://www.hcup‐us.ahrq.gov/nisoverview.jsp
Ayanian JZ, Udvarhelyi IS, Gatsonis CA, Pashos CL, Epstein AM. Racial differences in the use of revascularization procedures after coronary angiography. JAMA. 1993;269:2642‐2646.
Yoder M, Dils A, Chakrabarti A, et al. Gender and race‐related disparities in the management of ventricular arrhythmias. Trends Cardiovasc Med. 2023:S1050173823000865.
Khalid U, Marzec LN, Mantini N, et al. Treatment of AF in American Indians and Alaska Natives: insights from the NCDR PINNACLE‐AF registry. J Am Coll Cardiol. 2020;75:2749‐2750.
Hamade H, Jabri A, Mishra P, Butt MU, Sallam S, Karim S. Gender, ethnic, and socioeconomic differences in access to catheter ablation therapy in patients with atrial fibrillation. Front Cardiovasc Med. 2022;9:966383.
Toy J. Racial and ethnic disparities amongst patients with lay rescuer automated external defibrillator placement after out‐of‐hospital cardiac arrest. Resuscitation. 2023;190:109902.
Wang DR, Li J, Parikh RV, et al. Racial/ethnic disparities in outcomes after percutaneous coronary intervention. Am J Cardiol. 2023;205:120‐125.
Kipp R, Kalscheur M, Sheehy AM, Bartels CM, Kind AJH, Powell WR. Race, sex, and neighborhood socioeconomic disparities in ablation of ventricular tachycardia within a national medicare cohort. J Am Heart Assoc. 2022;11:e027093.
Harari L, Lee C. Intersectionality in quantitative health disparities research: a systematic review of challenges and limitations in empirical studies. Soc Sci Med. 2021;277:113876.
Lee C, Park S, Boylan JM. Cardiovascular health at the intersection of race and gender: identifying life‐course processes to reduce health disparities. J Gerontol B Psychol Sci Soc Sci. 2020;76:1127‐1139.
Curtis LH, Al‐Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverter‐defibrillators for primary and secondary prevention of sudden cardiac death. JAMA. 2007;298:1517‐1524.
Johnson AE, Adhikari S, Althouse AD, et al. Persistent sex disparities in implantable cardioverter‐defibrillator therapy. Pacing Clin Electrophysiol. 2018;41:1150‐1157.
Ingelaere S, Hoffmann R, Guler I, et al. Inequality between women and men in ICD implantation. Int J Cardiol Heart Vasc. 2022;41:101075.
Peterson PN, Daugherty SL, Wang Y, et al. Gender differences in procedure‐related adverse events in patients receiving implantable cardioverter‐defibrillator therapy. Circulation. 2009;119:1078‐1084.
Han JK, Russo AM. Underrepresentation of women in implantable cardioverter defibrillator trials. Am Heart J Plus. 2022;14:100120.
Ghanbari H, Dalloul G, Hasan R, et al. Effectiveness of implantable cardioverter‐defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta‐analysis of randomized controlled trials. Arch Intern Med. 2009;169:1500‐1506.
Zeitler EP, Hellkamp AS, Schulte PJ, et al. Comparative effectiveness of implantable cardioverter defibrillators for primary prevention in women. Circ Heart Fail. 2016;9:e002630.
Shahu A, Okunrintemi V, Tibuakuu M, et al. Income disparity and utilization of cardiovascular preventive care services among U.S. adults. Am J Prev Cardiol. 2021;8:100286.
Abdalla SM, Yu S, Galea S. Trends in cardiovascular disease prevalence by income level in the United States. JAMA Netw Open. 2020;3:e2018150.
Eberly LA, Day SM, Ashley EA, et al. Association of race with disease expression and clinical outcomes among patients with hypertrophic cardiomyopathy. JAMA Cardiol. 2020;5:83‐91.
Cook NL, Ayanian JZ, Orav EJ, Hicks LS. Differences in specialist consultations for cardiovascular disease by race, ethnicity, gender, insurance status, and site of primary care. Circulation. 2009;119:2463‐2470.
Essien UR, Holmes DN, Jackson LR, et al. Association of race/ethnicity with oral anticoagulant use in patients with atrial fibrillation. JAMA Cardiol. 2018;3:1174‐1182.
De Bruin ML, van Hemel NM, Leufkens HGM, Hoes AW. Hospital discharge diagnoses of ventricular arrhythmias and cardiac arrest were useful for epidemiologic research. J Clin Epidemiol. 2005;58:1325‐1329.
Khalil M, Maraey A, Aglan A, et al. Impact of chronic kidney disease on in‐hospital mortality and clinical outcomes of catheter ablation of ventricular tachycardia: insights from the national readmission database. J Interv Card Electrophysiol. 2023;66:323‐331.
Moustafa A, Elzanaty A, Karim S, et al. Outcomes of ventricular tachycardia catheter ablation in patients who underwent cardiac defibrillator implantation nationwide readmission database analysis. Am J Cardiol. 2023;198:108‐112.